Fourth-quarter and 2017 accounts reflect the acquisition of the former Boehringer Ingelheim Consumer Healthcare (CHC) business and the disposal of the Animal Health business (completed on January 1  2017) In accordance with IFRS 5 (Non-Current Assets Held for Sale and Discontinued Operations)  Animal Health results in 2016 and gain on disposal in 2017 are reported separately